Cogent Biosciences, Inc. (COGT) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$36.04
Day's range
$37.71

Cogent Biosciences Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 02/17/2026 23.09 M $820.05 M   3.03% 20.17%
BLACKROCK, INC. 02/12/2026 12.97 M $460.86 M   25.12% 19.19%
VANGUARD GROUP INC 01/29/2026 11.51 M $408.99 M   48.43% 17.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 02/17/2026 9.04 M $321.24 M   -0.10% 13.38%
RTW INVESTMENTS, LP 02/17/2026 7.59 M $269.68 M   118.96% 11.23%
FAIRMOUNT FUNDS MANAGEMENT LLC 02/17/2026 9.00 M $319.80 M   0.00% 7.87%
STATE STREET CORP 02/13/2026 4.94 M $175.48 M   3.45% 7.31%
KYNAM CAPITAL MANAGEMENT, LP 02/17/2026 6.17 M $218.99 M   -21.82% 5.39%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 3.51 M $124.86 M   7.34% 5.20%
TCG CROSSOVER MANAGEMENT, LLC 02/17/2026 5.87 M $208.44 M   -13.68% 5.13%
JANUS HENDERSON GROUP PLC 02/17/2026 4.54 M $161.11 M   42.77% 3.96%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 2.56 M $91.08 M   2,757.98% 3.79%
VIVO CAPITAL, LLC 02/13/2026 2.40 M $85.21 M   -13.99% 3.55%
OCTAGON CAPITAL ADVISORS LP 02/17/2026 2.35 M $83.47 M   -18.24% 3.48%
DUQUESNE FAMILY OFFICE LLC 02/17/2026 2.21 M $78.66 M   109.00% 3.28%
COMMODORE CAPITAL LP 02/17/2026 2.20 M $78.03 M   -69.70% 3.25%
GOLDMAN SACHS GROUP INC 03/25/2026 1.71 M $60.57 M   2.74% 2.52%
MARSHALL WACE, LLP 02/13/2026 1.66 M $58.99 M   158.49% 2.46%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 2.71 M $96.34 M   566.59% 2.37%
CITADEL ADVISORS LLC 02/17/2026 1.44 M $51.11 M   -13.72% 2.13%
D. E. SHAW & CO., INC. 02/17/2026 2.25 M $79.84 M   46.83% 1.96%
CANDRIAM S.C.A. 04/30/2026 1.30 M $46.05 M   35.87% 1.92%
MILLENNIUM MANAGEMENT LLC 02/17/2026 1.21 M $42.92 M   191.16% 1.79%
BANK OF AMERICA CORP /DE/ 02/17/2026 1.19 M $42.34 M   -46.77% 1.76%
VR ADVISER, LLC 02/17/2026 2.00 M $71.04 M   -50.00% 1.75%
HOLOCENE ADVISORS, LP 02/17/2026 1.18 M $41.85 M   899.19% 1.74%
02/17/2026 1.17 M $41.58 M   100.00% 1.73%
SOFINNOVA INVESTMENTS, INC. 02/13/2026 1.97 M $70.10 M   -7.25% 1.72%
LORD, ABBETT & CO. LLC 02/13/2026 1.87 M $66.44 M   100.00% 1.63%
FRED ALGER MANAGEMENT, LLC 02/17/2026 1.10 M $39.15 M   100.00% 1.63%
SIREN, L.L.C. 02/13/2026 1.63 M $57.87 M   -5.51% 1.42%
EMERALD ADVISERS, LLC 02/09/2026 1.58 M $56.24 M   0.24% 1.38%
NUVEEN, LLC 02/12/2026 932.62 K $33.13 M   -0.74% 1.38%
AMERICAN CENTURY COMPANIES INC 02/13/2026 892.92 K $31.72 M   100.00% 1.32%
BALYASNY ASSET MANAGEMENT L.P. 02/17/2026 1.44 M $51.16 M   -46.07% 1.26%
REDMILE GROUP, LLC 02/17/2026 1.44 M $51.07 M   -34.91% 1.26%
WOODLINE PARTNERS LP 02/17/2026 818.78 K $29.08 M   59.48% 1.21%
02/17/2026 780.00 K $27.71 M   100.00% 1.15%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 1.28 M $45.49 M   7.57% 1.12%
SILVERARC CAPITAL MANAGEMENT, LLC 02/12/2026 1.25 M $44.23 M   52.78% 1.09%
MORGAN STANLEY 02/13/2026 726.78 K $25.82 M   -43.58% 1.08%
SATURN V CAPITAL MANAGEMENT LLC 02/17/2026 1.22 M $43.23 M   -39.90% 1.06%
NORTHERN TRUST CORP 02/17/2026 1.20 M $42.60 M   1.49% 1.05%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 689.07 K $24.48 M   195.78% 1.02%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 02/17/2026 668.97 K $23.76 M   100.00% 0.99%
EMERALD MUTUAL FUND ADVISERS TRUST 02/09/2026 1.04 M $36.89 M   1.53% 0.91%
INVESCO LTD. 02/19/2026 585.77 K $20.81 M   57.35% 0.87%
02/13/2026 568.62 K $20.20 M   100.00% 0.84%
ATIKA CAPITAL MANAGEMENT LLC 02/13/2026 506.00 K $17.97 M   100.00% 0.75%
ROCK SPRINGS CAPITAL MANAGEMENT LP 02/17/2026 849.03 K $30.16 M   -15.80% 0.74%

Cogent Biosciences Inc institutional Ownership - FAQ's

During the previous two years, 343 institutional investors and hedge funds held shares of Cogent Biosciences Inc. The most heavily invested institutionals were:

Invesco Ltd.: 2.43 M

Pictet Asset Management Holding SA: 1.8 M

EMERALD ADVISERS, LLC: 1.59 M

Candriam S.C.A.: 1.52 M

VANGUARD FIDUCIARY TRUST CO: 1.06 M

EMERALD MUTUAL FUND ADVISERS TRUST: 1.03 M

257.52% of Cogent Biosciences Inc stock is owned by institutional investors.

Institutional investors have bought a total of 187.92 M shares in the last 24 months. This purchase volume represents approximately $6.95 B in transactions.